European Neuropsychopharmacology Journal Citation Rate 2026

ISSN 0924-977X eISSN 1873-7862 Elsevier BV NL

Q3 Quartile

About European Neuropsychopharmacology
{# Self-contained "answer block": one dense, LLM-quotable paragraph stating every core fact with an explicit as-of year, server-rendered and unique per journal. This is the canonical fact statement — other sections add narrative, they do not restate these numbers. #}

European Neuropsychopharmacology (EN) is a peer-reviewed academic journal, published by Elsevier BV in NL, catalogued under ISSN 0924-977X (e-ISSN 1873-7862). As of 2026, it has a 2025 2-Year Citation Rate (OpenAlex) of 1.12 (Q3 quartile) — the average number of citations its recent articles received over a two-year window, computed from OpenAlex open citation data, not the Clarivate (JCR) Impact Factor. It operates a subscription model.

European Neuropsychopharmacology Citation Rate 2026 — In Context

European Neuropsychopharmacology has a 2025 2-Year Citation Rate (OpenAlex) of 1.12, placing it in the Q3 quartile. This is the average number of citations the journal's recent articles received over a two-year window, computed from OpenAlex open citation data — not the Clarivate (JCR) Journal Impact Factor.

European Neuropsychopharmacology operates a subscription-based publishing model — readers access articles through institutional subscriptions or pay-per-view.

Researchers looking to publish in European Neuropsychopharmacology should review the journal's submission tips and verify the latest indexing status against Scopus, DOAJ, and Web of Science using our indexing tracker. To compare European Neuropsychopharmacology against similar journals in the field, use our journal comparison tool.

ISSN (Print) 0924-977X
ISSN (Online) 1873-7862
Publisher Elsevier BV
Country Netherlands
APC / Cost Inquire with Publisher
In-depth profile & metrics

European Neuropsychopharmacology is published by Elsevier BV and based in Netherlands.

Its most recent citation rate stands at 1.123.

Links
Frequently Asked Questions about European Neuropsychopharmacology

European Neuropsychopharmacology does not hold a Clarivate (JCR) Impact Factor on JournalsHub. Its 2-year citation rate, computed from OpenAlex open citation data, is 1.123 — an open proxy for citation impact, not the licensed JCR Impact Factor.

No, European Neuropsychopharmacology is not an open access journal.

European Neuropsychopharmacology is published by Elsevier BV.

European Neuropsychopharmacology is not currently listed in the major indexes we track (Scopus, DOAJ, Web of Science). This is not evidence of predatory practice — many legitimate new or regional journals are not yet indexed — but you should verify its peer-review process, editorial board, and indexing directly with the publisher before submitting.

The ISSN of European Neuropsychopharmacology is 0924-977X. Its electronic ISSN (eISSN) is 1873-7862.

European Neuropsychopharmacology sits in the Q3 quartile based on its latest impact factor of 1.12, ranked across all journals in our database.
Live Indexing Status
Updated July 2026

Track real-time indexing metrics to ensure this journal meets your academic requirements.

OpenAlex
Unverified
DOAJ
Non-OA
Predatory Check
Clean
Citation Rate
1.123
2-Year Citation Rate (OpenAlex) · 2025
Historical Trend
Initial data points only
Citation Rate by Year
Year Value Source
2025 1.123 2-Year Mean Citedness (OpenAlex)

Metrics are sourced from OpenAlex, DOAJ and Scopus and reflect the latest data we hold. The headline figure is a 2-year citation rate (OpenAlex), not a Clarivate Impact Factor. Always verify against the journal's official site before relying on it. See our Methodology or report a correction.

Research Highlights

Recently published high-impact papers in this journal:

Metadata

Last updated: Jul 12, 2026

Updated by: system

Get weekly updates

Free. Monday morning. New citation rates, CFPs, indexing alerts, predatory watch list. One-click unsubscribe.

Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now
Compare 0 Open → Clear
Save your viewing history
You've browsed several journals this session. Sign in to track them in one place and get weekly impact-factor updates.
Save with Google